Literature DB >> 22535990

Seronegative hepatitis C virus infection in a child infected via mother-to-child transmission.

Ariane Larouche1, Geneviève Gaëtan, Nabil El-Bilali, Mathieu Quesnel-Vallières, Steven R Martin, Fernando Alvarez, Naglaa H Shoukry, Hugo Soudeyns.   

Abstract

Hepatitis C virus (HCV) infection typically leads to antibody response within weeks after primary infection. Here, we describe the case of a child infected with HCV by mother-to-child transmission who remained persistently seronegative despite the presence of high levels of circulating HCV RNA.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22535990      PMCID： PMC3405620          DOI： 10.1128/JCM.00622-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  34 in total

1.  Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women.

Authors:  D Conte; M Fraquelli; D Prati; A Colucci; E Minola
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

2.  Risk factors for mother-to-child transmission of hepatitis C virus: Maternal high viral load and fetal exposure in the birth canal.

Authors:  Jun Murakami; Ikuo Nagata; Toshiyuki Iitsuka; Manabu Okamoto; Shunsaku Kaji; Tadataka Hoshika; Ryu Matsuda; Susumu Kanzaki; Kazuo Shiraki; Akihiko Suyama; Shigeo Hino
Journal:  Hepatol Res       Date:  2012-03-08       Impact factor: 4.288

3.  Hepatitis C virus infection of human T lymphocytes is mediated by CD5.

Authors:  Mohammed A Sarhan; Tram N Q Pham; Annie Y Chen; Tomasz I Michalak
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests.

Authors:  W N Schmidt; P Wu; J Cederna; F A Mitros; D R LaBrecque; J T Stapleton
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

5.  Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study.

Authors:  O Ceci; M Margiotta; F Marello; R Francavilla; P Loizzi; A Francavilla; A Mautone; L Impedovo; E Ierardi; M Mastroianni; S Bettocchi; L Selvaggi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-11       Impact factor: 2.839

6.  Prospective study of mother-to-infant transmission of hepatitis C virus (HCV) infection. Study Group for Vertical Transmission.

Authors:  C Mazza; A Ravaggi; A Rodella; D Padula; M Duse; M Lomini; M Puoti; A Rossini; E Cariani
Journal:  J Med Virol       Date:  1998-01       Impact factor: 2.327

7.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

Authors:  P Farci; A Shimoda; A Coiana; G Diaz; G Peddis; J C Melpolder; A Strazzera; D Y Chien; S J Munoz; A Balestrieri; R H Purcell; H J Alter
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

Review 8.  Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections.

Authors:  Ari J Fried; Francisco A Bonilla
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

9.  Degree of diversity of hepatitis C virus quasispecies and progression of liver disease.

Authors:  M Honda; S Kaneko; A Sakai; M Unoura; S Murakami; K Kobayashi
Journal:  Hepatology       Date:  1994-11       Impact factor: 17.425

10.  Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1.

Authors:  Sophie Canobio; Cynthia M Guilbert; Myriam Troesch; Johanne Samson; Mireille Lemay; Veronique Anne Pelletier; Anne-Claude Bernard-Bonnin; Rafal Kozielski; Normand Lapointe; Steven R Martin; Hugo Soudeyns
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948
View more
  7 in total

1.  Vertical Transmission of Hepatitis C Virus: Variable Transmission Bottleneck and Evidence of Midgestation In Utero Infection.

Authors:  Sébastien Fauteux-Daniel; Ariane Larouche; Virginie Calderon; Jonathan Boulais; Chanel Béland; Doris G Ransy; Marc Boucher; Valérie Lamarre; Normand Lapointe; Isabelle Boucoiran; Armelle Le Campion; Hugo Soudeyns
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 2.  Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

Authors:  Maria Victoria Preciado; Pamela Valva; Alejandro Escobar-Gutierrez; Paula Rahal; Karina Ruiz-Tovar; Lilian Yamasaki; Carlos Vazquez-Chacon; Armando Martinez-Guarneros; Juan Carlos Carpio-Pedroza; Salvador Fonseca-Coronado; Mayra Cruz-Rivera
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

3.  Vertical transmission of hepatitis C virus: a tale of multiple outcomes.

Authors:  Alejandro Escobar-Gutiérrez; Hugo Soudeyns; Ariane Larouche; Juan Carlos Carpio-Pedroza; Armando Martinez-Guarneros; Carlos A Vazquez-Chacon; Salvador Fonseca-Coronado; Lilian H T Yamasaki; Karina Ruiz-Tovar; Mayra Cruz-Rivera
Journal:  Infect Genet Evol       Date:  2013-10-18       Impact factor: 3.342

Review 4.  Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression.

Authors:  Pier-Angelo Tovo; Carmelina Calitri; Carlo Scolfaro; Clara Gabiano; Silvia Garazzino
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 5.  Seronegative hepatitis C virus infection.

Authors:  Justyna Kaźmierczak; Agnieszka Pawełczyk; Kamila Caraballo Cortes; Marek Radkowski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-11-09       Impact factor: 4.291

Review 6.  Advanced molecular surveillance of hepatitis C virus.

Authors:  Livia Maria Gonçalves Rossi; Alejandro Escobar-Gutierrez; Paula Rahal
Journal:  Viruses       Date:  2015-03-13       Impact factor: 5.048

Review 7.  Pathogenesis of hepatitis C during pregnancy and childhood.

Authors:  Armelle Le Campion; Ariane Larouche; Sébastien Fauteux-Daniel; Hugo Soudeyns
Journal:  Viruses       Date:  2012-12-06       Impact factor: 5.048
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.